Search results
Akari Therapeutics (NASDAQ:AKTX) Now Covered by StockNews.com
ETF DAILY NEWS· 2 days agoResearch analysts at StockNews.com assumed coverage on shares of Akari Therapeutics (NASDAQ:AKTX – Get Free Report) in a research report issued on Wednesday. The brokerage set a “sell” rating ...
Cognition Therapeutics KOL Event Provided Platform for Valuable Discussion of Current Therapeutic...
Morningstar· 3 days ago(Jort) Vijverberg, MD, PhD of the Alzheimer Center Amsterdam and Neuroscience Amsterdam. “The KOL roundtable we conducted featured a panel of Alzheimer’s disease expert clinicians and researchers ...
12 Cheap Foods With Anti-Aging Properties That Longevity Scientists Swear By
Insider Monkey via Yahoo Finance· 6 days agoIn this article, we will be taking a look at the 12 cheap foods with anti-aging properties that...
HC Wainwright Comments on Unity Biotechnology, Inc.’s Q1 2024 Earnings (NASDAQ:UBX)
ETF DAILY NEWS· 7 days agoUnity Biotechnology, Inc. (NASDAQ:UBX – Free Report) – Stock analysts at HC Wainwright issued their Q1 2024 EPS estimates for Unity Biotechnology in a research report issued on Tuesday, April ...
Local women with low vision gather to share experiences, advances in tech
telegraphherald.com· 5 days agoA group of nearly 20 women who either have low vision or are a friend or caregiver of someone with...
Brokers Offer Predictions for Unity Biotechnology, Inc.’s FY2024 Earnings (NASDAQ:UBX)
ETF DAILY NEWS· 6 days agoUnity Biotechnology, Inc. (NASDAQ:UBX – Free Report) – Equities research analysts at HC Wainwright raised their FY2024 EPS estimates for shares of Unity Biotechnology in a note issued to investors ...
Apellis Pharmaceuticals, Inc. Expected to Earn Q2 2025 Earnings of $0.23 Per Share (NASDAQ:APLS)
ETF DAILY NEWS· 2 days agoApellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) – Zacks Research upped their Q2 2025 EPS estimates for Apellis Pharmaceuticals in a report issued on Tuesday, April 23rd. Zacks Research ...
Skye Bioscience (SKYE) versus Its Rivals Critical Survey
ETF DAILY NEWS· 5 days agoSkye Bioscience (NASDAQ:SKYE – Get Free Report) is one of 960 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it compare to its rivals? We will compare ...
Mirae Asset Global Investments Co. Ltd. Reduces Holdings in REGENXBIO Inc. (NASDAQ:RGNX)
ETF DAILY NEWS· 5 days agoMirae Asset Global Investments Co. Ltd. trimmed its position in shares of REGENXBIO Inc. (NASDAQ:RGNX – Free Report) by 54.7% in the 4th quarter, according to its most recent disclosure with ...
Dear Doctor: Possible ALS patient frustrated by request for second opinion that goes nowhere
OregonLive.com· 3 days agoROACH: My question is about amyotrophic lateral sclerosis (ALS). Nary a test was done; the neurologist looked at the electromyography (EMG) done by a neuromuscular doctor at another facility ...
